Hypoglycemic News and Research

RSS

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

In a new study, scientists from University of Copenhagen document a connection between congenital arrhythmia and the bodies' ability to handle sugar. The results can be of vital importance for patients with the disease and for the future treatment of diabetes. The new study has just been published in the scientific journal Diabetes.

19 Dec 2013

Older people with diabetes are susceptible to nonfatal cardiovascular complications, hypoglycemic events

Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Dec 2013

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today reported preliminary data from the Company's ongoing extension study of a Phase I/II clinical trial with its lead product Glassia® to treat pediatric patients with a recently diagnosed type 1 diabetes (T1D).

31 Oct 2013

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.

28 Oct 2013

Dietary modifications can reduce gastroparesis in diabetes patients

Many diabetes patients suffer from symptoms such as nausea, vomiting and lack of appetite. A doctoral thesis from the Sahlgrenska Academy shows that a diet consisting of foods that fall apart easily, for example boiled potatoes and fish gratin, can help alleviate the condition.

5 Oct 2013

Use of insulin pump with sensor reduces rate of severe hypoglycemia

Use of an insulin pump with a sensor that suspends insulin delivery when blood glucose falls below a set threshold reduced the rate of severe and moderate hypoglycemia among patients with type 1 diabetes and impaired awareness of hypoglycemia, according to a study in the September 25 issue of JAMA.

25 Sep 2013

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Boehringer Ingelheim and Eli Lilly and Company today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the safety of the dipeptidyl peptidase-4 inhibitor linagliptin in adults with type 2 diabetes.

24 Sep 2013

Researchers report encouraging results from T1DAL study on type 1 diabetes

Encouraging results from the T1DAL study (Targeting effector memory T cells with alefacept in new onset type 1 diabetes), led by Mark R. Rigby MD, PhD from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published today in The Lancet Diabetes & Endocrinology.

23 Sep 2013

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

The Diabetes Hands Foundation announced today that it will send diabetes advocate Bennet Dunlap to participate on a panel September 9, 2013 aiming to address the growing concerns around blood glucose test strip accuracy.

7 Sep 2013

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

TechAtlas Group has announced the release of the latest Type 1 Diabetes competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development.

6 Sep 2013

Diabetic patients could benefit from breakthrough cell study

Diabetic patients could benefit from a breakthrough that enables scientists to take cells from the pancreas and change their function to produce insulin.

30 Aug 2013

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

People with type 1 diabetes who rely on insulin injections to control their blood sugar levels are at risk for life-threatening hypoglycemic events in which their blood glucose levels drop dangerously low.

25 Jun 2013

Study finds that triple therapy corrects two core defects in type 2 diabetes

Patients with type 2 diabetes fare significantly better if they are started on three medications at the time of diagnosis than if they are prescribed a single drug and have other therapies added later, a San Antonio researcher said June 22 at the 73rd Scientific Sessions of the American Diabetes Association in Chicago.

25 Jun 2013

Sanofi reports Phase 3 study of insulin U300 shows better blood sugar control than Lantus

Sanofi announced today that the first Phase 3 study results for its investigational new insulin U300 showed equivalent blood sugar control with fewer night-time low blood sugar events compared to Lantus.

24 Jun 2013

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that comprehensive data from a study of the company's PaQ Insulin Delivery Device will be presented today and tomorrow at the American Diabetes Association 73rd Scientific Sessions in Chicago, IL. The data suggest that PaQ can reduce known barriers to insulin therapy among people with type 2 diabetes, potentially improving their glycemic control.

24 Jun 2013

Hypoglycemic News and Research

Copenhagen scientists study link between congenital arrhythmia and hypoglycemia

Older people with diabetes are susceptible to nonfatal cardiovascular complications, hypoglycemic events

Kamada announces new data from Glassia Phase I/II study in pediatric patients with type 1 diabetes

DPP-4 inhibitors may reduce risk of autoimmune diseases

Dietary modifications can reduce gastroparesis in diabetes patients

Use of insulin pump with sensor reduces rate of severe hypoglycemia

Boehringer Ingelheim, Lilly present post-hoc analysis data from linagliptin clinical trials at EASD 2013

Researchers report encouraging results from T1DAL study on type 1 diabetes

Experts and patient advocates to discuss growing concerns around blood glucose test strip accuracy

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

Diabetic patients could benefit from breakthrough cell study

Promising approach to reduce risk of hypoglycemia in diabetes shows positive results

Study finds that triple therapy corrects two core defects in type 2 diabetes

Sanofi reports Phase 3 study of insulin U300 shows better blood sugar control than Lantus

New data suggest PaQ device can reduce known barriers to insulin therapy among people with type 2 diabetes

Diabetes may increase risk for developing Alzheimer’s and vascular dementia

Case Western Reserve University receives grant to research on glucose-responsive insulin

Artificial pancreas outperforms insulin pump in diabetes camp

Minimally invasive islet transplantation reverses progression of atherosclerosis in type 1 diabetics

Communication key in helping patients adhere to medicine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News